Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2027

The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, and neurological diseases. However high cost of plasma products and the lack of sufficient reimbursements, increasing adoption of on-demand recombinant factors, and shortage of plasma for manufacturing plasma fractionation products are expected to restrain the growth of this market to a certain extent during the forecast period.

“The hospitals and clinicssegmentis expected to dominate the market during the forecast period.”

Based on end user, the plasma fractionation market is segmented into hospitals and clinics, clinical research laboratories, and academic institutes. In 2021, the hospitals and clinics segment accounted for the largest share of the global plasma fractionation market. The large share of this segment is attributed the improving healthcare infrastructure and growth in the number of hospitals & clinics in the emerging and established econmies. Leading players in this market are collaborating with hospitals to raise awareness about the treatment of rare diseases using plasma products and carry out clinical trials with hospital collaboration.Such initiatives by companies and hospitals are expected to drive the demand for plasma products for the treatment of various rare and life-threatening diseases such as hemophilia, PID, and COVID-19.

“The pulmonology application segment will witness the highest growth intheplasma fractionation market.”

Based on application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2021, the pulmonology segment is expected to register the highest CAGR during the forecast period. Immunoglobulins and protease inhibitors are the major plasma products used in the treatment of various respiratory diseases. Immunoglobulins are mainly used to prevent and treat upper and lower respiratory tract infections. In recent years, the use of protease inhibitors, such as alpha-1-antitrypsin, has increased significantly in the pulmonology segment, thus growing the market segment for pulmonology application significantly.

“North America will dominate the market during the forecast period.”

Geographically, the plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the leading players adopting various organic and inorganic growth strategies to strengthen their market positions. The expansion of fractionation plants with state-of-the-art technologies is a key growth strategy followed by major players in this market in the region. Leading players also focus on acquiring plasma collection centers to expand their presence in North America.

The primary interviews conducted for this report can be categorized as follows:

By Company Type -Tier 1: 37%, Tier 2: 23%,and Tier 3: 40%

By Designation - C-level:32%, D-level:26%, and Others:42%

By Region - North America:35%, Europe:25%, Asia Pacific:20%, Latin America: 12%, and the Middle East and Africa: 8%

List of Companies Profiled in the Report

CSL (Australia)

Grifols, S.A. (Spain)

Shire (US)

Octapharma AG (Switzerland)

Kedrion S.P.A (Italy)

LFB (France)

Biotest AG (Germany)

Sanquin (Netherlands)

China Biologic Products Holdings Inc. (China)

GC Pharma (Korea)

Bio Products Ltd. (UK)

Japan Blood Products Organization (Japan)

Emergent BioSolutions (US)

Shanghai Raas Blood Products Co., Ltd. (China)

Intas Pharmaceuticals Ltd. (India)

Bharat Serum Vaccines Limited (India)

SK Plasma (Korea)

Sichuan YuandaShuyang Pharmaceutical Co., Ltd. (China)

KabaFusion (US)

Centurion Pharma (Istanbul)

ADMA Biologics, Inc. (US)

PlasmaGenBioSciences Pvt. Ltd. (India)

Virchow Biotech Private Limited (India)

Fusion Healthcare (India)

Hemarus Therapeutics Limited (India)

Research Coverage:

This report provides a detailed picture of the global plasma fractionationmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total plasma fractionation market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on plasma fractionation offered by the top 25 players in the plasma fractionation market. The report analyses the plasma fractionation market by product,application, end user, and region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various plasma fractionation across key geographic regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma fractionationmarket.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the plasma fractionationmarket.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET ESTIMATION METHODOLOGY
      • INSIGHTS FROM PRIMARY EXPERTS
    • MARKET GROWTH RATE PROJECTIONS
      • DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
      • COVID-19 ASSUMPTIONS
    • RISK ANALYSIS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PLASMA FRACTIONATION MARKET OVERVIEW
    • NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT & COUNTRY (2019)
    • PLASMA FRACTIONATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
      • MARKET DYNAMICS
    • MARKET DYNAMICS
      • Table PLASMA FRACTIONATION MARKET: IMPACT ANALYSIS
      • MARKET DRIVERS
        • Table ON-LABEL AND OFF-LABEL INDICATIONS OF IVIG
        • Table NUMBER OF CLINICAL STUDIES ON IMMUNOGLOBULINS, BY REGION (AS OF 2020-2021)
        • Table NUMBER OF PATIENTS TREATED FOR TOP 15 TARGET CONDITIONS IN THE UK
        • Table GERIATRIC POPULATION, BY REGION, 2000-2050
      • MARKET RESTRAINTS
      • MARKET OPPORTUNITIES
        • Table NUMBER OF HEMOPHILIA PATIENTS IN DEVELOPED AND EMERGING COUNTRIES, 2016 VS. 2018
      • MARKET CHALLENGES
    • IMPACT ASSESSMENT OF PLASMA FRACTIONATION MARKET
    • PRICING ANALYSIS
      • Table AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS, BY KEY PLAYER, 2021 (USD)
      • Table AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS, BY REGION, 2021 (USD)
    • IMPACT OF COVID-19 ON MARKET DYNAMICS
      • DRIVERS AND OPPORTUNITIES
      • RESTRAINTS AND CHALLENGES
      • CUMULATIVE GROWTH ANALYSIS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS
      • Table SUPPLY CHAIN ECOSYSTEM
    • PATENT ANALYSIS
      • Table INDICATIVE LIST OF PATENTS IN THE PLASMA FRACTIONATION MARKET
    • KEY CONFERENCES AND EVENTS IN 2022-2023
      • Table PLASMA FRACTIONATION MARKET: LIST OF CONFERENCES AND EVENTS
    • REGULATORY ANALYSIS
      • LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
      • REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES
    • PORTER'S FIVE FORCES ANALYSIS
      • Table PLASMA FRACTIONATION MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • DEGREE OF COMPETITION
    • TECHNOLOGY ANALYSIS
      • COHN'S COLD ETHANOL PLASMA FRACTIONATION
      • GEL FILTRATION PLASMA FRACTIONATION
      • HUMAN PLASMA FRACTIONATION BY POLYETHYLENE GLYCOL
      • PLASMA FRACTIONATION BY AMMONIUM SULFATE
    • KEY STAKEHOLDERS AND BUYING CRITERIA
    • KEY BUYING CRITERIA BY END USERS
  • PLASMA FRACTIONATION MARKET, BY PRODUCT
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • IMMUNOGLOBULINS
      • Table IVIG VS. SCIG THERAPY
      • Table PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY REGION, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • INTRAVENOUS IMMUNOGLOBULINS
        • Table INTRAVENOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • SUBCUTANEOUS IMMUNOGLOBULINS
        • Table SUBCUTANEOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
      • OTHER IMMUNOGLOBULINS
        • Table OTHER IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020-2027 (USD MILLION)
    • COAGULATION FACTOR CONCENTRATES
      • Table PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY REGION, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • FACTOR VIII
        • Table FACTOR VIII OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020-2027 (USD MILLION)
      • FACTOR IX
        • Table FACTOR IX OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020-2027 (USD MILLION)
      • VON WILLEBRAND FACTOR
        • Table VON WILLEBRAND FACTOR OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020-2027 (USD MILLION)
      • PROTHROMBIN COMPLEX CONCENTRATES
        • Table PROTHROMBIN COMPLEX CONCENTRATES OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • FIBRINOGEN CONCENTRATES
        • Table FIBRINOGEN CONCENTRATES OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020-2027 (USD MILLION)
      • FACTOR XIII
        • Table FACTOR XIII OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020-2027 (USD MILLION)
      • FACTOR XI
        • Table PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020-2027 (USD MILLION)
    • ALBUMIN
      • RISING DEMAND FOR ALBUMIN AS AN ANTIOXIDANT TO DRIVE MARKET GROWTH
        • Table ALBUMIN OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020-2027 (USD MILLION)
    • PROTEASE INHIBITORS
      • RISING PREVALENCE OF COPD WILL DRIVE THE DEMAND FOR PROTEASE INHIBITORS
        • Table PROTEASE INHIBITORS OFFERED BY KEY MARKET PLAYERS
        • Table PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020-2027 (USD MILLION)
    • OTHER PLASMA PRODUCTS
      • Table PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • NEUROLOGY
      • RISING PREVALENCE OF MAJOR AGE-RELATED NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
        • Table NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS AND THE PERCENTAGE OF DALYS PROJECTED FOR 2005, 2015, AND 2030
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN NEUROLOGY
        • Table PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • IMMUNOLOGY
      • INCREASING PREVALENCE OF IMMUNODEFICIENCY DISORDERS AMONG CHILDREN AND ADULTS WILL DRIVE THE GROWTH OF THIS MARKET
        • Table LIST OF FDA-APPROVED INDICATIONS FOR IMMUNOGLOBULINS IN IMMUNOLOGY
        • Table DIAGNOSIS DISTRIBUTION OF DIFFERENT CATEGORIES OF PRIMARY IMMUNODEFICIENCY DISEASE
        • Table PREVALENCE OF PRIMARY IMMUNODEFICIENCY DISEASE, BY REGION, 2013 VS. 2015
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN IMMUNOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • HEMATOLOGY
      • GROWTH IN THE NUMBER OF HEMOPHILIA PATIENTS TO DRIVE THE DEMAND FOR COAGULATION FACTOR CONCENTRATES AND IMMUNOGLOBULINS
        • Table NUMBER OF HEMOPHILIA PATIENTS (2012-2020)
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • CRITICAL CARE
      • INCREASING OFF-LABEL USE OF ALBUMIN AND RISING USE OF ANTICOAGULANTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED CRITICAL CARE PRODUCTS
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN CRITICAL CARE
        • Table PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • PULMONOLOGY
      • RISING PREVALENCE OF ALPHA-1-ANTITRYPSIN DEFICIENCY AND COPD TO DRIVE THE PLASMA FRACTIONATION MARKET FOR PULMONOLOGY
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN PULMONOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • HEMATO-ONCOLOGY
      • RISING NUMBER OF BLOOD CANCER PATIENTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED PRODUCTS
        • Table INCIDENCE OF LEUKEMIA, MULTIPLE MYELOMA, AND HODGKIN'S LYMPHOMA, BY REGION, 2012-2018
        • Table PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATO-ONCOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • RHEUMATOLOGY
      • INCREASING PREVALENCE OF RHEUMATIC CONDITIONS TO DRIVE THE PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY
        • Table PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • OTHER APPLICATIONS
      • Table PLASMA-DERIVED PRODUCTS FOR OTHER APPLICATIONS
      • Table PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY END USER
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • HOSPITALS & CLINICS
      • IMPROVING HEALTHCARE INFRASTRUCTURE AND GROWING NUMBER OF HOSPITALS & CLINICS-KEY FACTORS DRIVING GROWTH
        • Table PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • CLINICAL RESEARCH LABORATORIES
      • INCREASING NUMBER OF CLINICAL STUDIES ON NEW THERAPEUTIC INDICATIONS FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH
        • Table PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • ACADEMIC INSTITUTES
      • GROWING DEMAND FOR NEW DRUG MOLECULES TO DRIVE THE DEMAND FOR PLASMA PRODUCTS IN ACADEMIC INSTITUTES
        • Table PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
        • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table EUROPE: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, 2020-2027 (USD MILLION)
        • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES BY COUNTRY, 2020-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
  • PLASMA FRACTIONATION MARKET, BY REGION
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET, BY REGION, 2020-2027 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • US
        • Table US: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table US: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • CANADA
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • EUROPE
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • GERMANY
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • UK
        • Table UK: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table UK: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • FRANCE
        • Table NUMBER OF PEOPLE WITH BLEEDING DISORDERS IN FRANCE, 2012-2020
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • ITALY
        • Table PRODUCTION OF PLASMA PRODUCTS IN ITALY (2013, 2018, AND 2023-E)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • SPAIN
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: NUMBER OF HEMOPHILIA PATIENTS, BY COUNTRY, 2012-2018
        • Table ROE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • Table ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • CHINA
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • JAPAN
        • Table MEAN PER CAPITA FACTOR VIII AND IX USE IN JAPAN, 2014 VS. 2018 (IN IU/TOTAL POPULATION)
        • Table PATIENTS WITH BLEEDING DISORDERS IN JAPAN, 2014 VS. 2020
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • AUSTRALIA
        • Table TOTAL IG (GRAMS) USED IN AUSTRALIA, 2008/09-2017/18
        • Table AUSTRALIAN GOVERNMENT FUNDING FOR THE SUPPLY OF BLOOD AND BLOOD PRODUCTS, 2008-2018 (USD MILLION)
        • Table AUSTRALIA: BLOOD SECTOR OVERVIEW (2017-2018)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table AUSTRALIA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • INDIA
        • Table INDIA: NUMBER OF PATIENTS WITH BLEEDING DISORDERS, 2012-2018
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • VIETNAM
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table VIETNAM: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • INDONESIA
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table INDONESIA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • MALAYSIA
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table MALAYSIA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table ROAPAC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROAPAC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROAPAC: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table ROAPAC: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table BRAZIL: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • ROLATAM
        • Table ROLATAM: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table ROLATAM: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROLATAM: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROLATAM: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table ROLATAM: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • Table HEMOPHILIA PATIENTS IN THE MIDDLE EAST & AFRICA, BY COUNTRY, 2012-2020
      • Table PER CAPITA CONSUMPTION OF FACTORS IX AND VIII (IU/TOTAL POPULATION) IN SOUTH AFRICA, SAUDI ARABIA, AND IRAQ, 2012-2018
      • Table MEA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
      • Table MEA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      • Table MEA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
      • Table MEA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
      • Table MEA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
      • Table MEA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • TURKEY
        • Table TURKEY: DEMOGRAPHIC INDICATORS
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table TURKEY: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • SAUDI ARABIA
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • EGYPT
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table EGYPT: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • UAE
        • Table UAE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table UAE: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
      • REST OF THE MIDDLE EAST & AFRICA
        • Table HEMOPHILIA PATIENTS IN THE REST OF MIDDLE EAST & AFRICA, 2012-2018
        • Table ROMEA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
        • Table ROMEA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROMEA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020-2027 (USD MILLION)
        • Table ROMEA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
        • Table ROMEA: PLASMA FRACTIONATION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
    • MARKET SHARE ANALYSIS
      • Table PLASMA FRACTIONATION MARKET: DEGREE OF COMPETITION
    • REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • COMPANY EVALUATION QUADRANT
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY EVALUATION QUADRANT: START-UPS/SMES
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING
      • COMPANY PRODUCT & REGIONAL FOOTPRINT (25 COMPANIES)
      • COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
        • Table PRODUCT PORTFOLIO ANALYSIS: PLASMA FRACTIONATION MARKET (2021)
      • COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
        • Table REGIONAL REVENUE MIX: PLASMA FRACTIONATION MARKET (2021)
    • COMPETITIVE SCENARIO AND TRENDS
      • Table PRODUCT LAUNCHES & APPROVALS, JANUARY 2018-APRIL 2022
      • Table DEALS, JANUARY 2018-APRIL 2022
      • Table OTHER DEVELOPMENTS, JANUARY 2018-APRIL 2022
    • COMPETITIVE BENCHMARKING
      • Table PLASMA FRACTIONATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
      • Table PLASMA FRACTIONATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
  • COMPANY PROFILES
    • KEY PLAYERS
      • CSL
        • Table CSL: BUSINESS OVERVIEW
      • GRIFOLS, S.A.
        • Table GRIFOLS, S.A.: BUSINESS OVERVIEW
      • SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
        • Table SHIRE: BUSINESS OVERVIEW
      • OCTAPHARMA AG
        • Table OCTAPHARMA AG: BUSINESS OVERVIEW
      • KEDRION S.P.A
        • Table KEDRION S.P.A: BUSINESS OVERVIEW
      • LFB
        • Table LFB: BUSINESS OVERVIEW
      • BIOTEST AG
        • Table BIOTEST AG: BUSINESS OVERVIEW
      • SANQUIN
        • Table SANQUIN: BUSINESS OVERVIEW
      • CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
        • Table CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.: BUSINESS OVERVIEW
      • GC PHARMA
        • Table GC PHARMA: BUSINESS OVERVIEW
      • BIO PRODUCTS LABORATORY LTD.
        • Table BIO PRODUCTS LABORATORY LTD.: BUSINESS OVERVIEW
      • JAPAN BLOOD PRODUCTS ORGANIZATION
        • Table JAPAN BLOOD PRODUCTS ORGANIZATION: BUSINESS OVERVIEW
      • EMERGENT BIOSOLUTIONS
        • Table EMERGENT BIOSOLUTIONS: BUSINESS OVERVIEW
      • SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
        • Table SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: BUSINESS OVERVIEW
      • INTAS PHARMACEUTICALS LTD.
        • Table INTAS PHARMACEUTICALS LTD.: BUSINESS OVERVIEW
    • OTHER COMPANIES
      • BHARAT SERUMS AND VACCINES LIMITED
      • SK PLASMA
      • SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD.
      • KABAFUSION
      • CENTURION PHARMA
      • ADMA BIOLOGICS, INC.
      • PLASMAGEN BIOSCIENCES PVT. LTD.
      • VIRCHOW BIOTECH PRIVATE LIMITED
      • FUSION HEALTHCARE
      • HEMARUS THERAPEUTICS LIMITED
  • APPENDIX
    • DISCUSSION GUIDE
    • AVAILABLE CUSTOMIZATIONS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook